Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
WuXi Healthcare Ventures
AddedFeb 13, 2024
UpdatedJul 16, 2026
WuXi Healthcare Ventures

WuXi Healthcare Ventures

Operating

WuXi Healthcare Ventures: A Chinese firm investing in life sciences for transformative therapies.

Location
Cambridge, MA, US
Founded
2011
Firm
Compare
Portfolio
Employees

WuXi Healthcare Ventures is a Chinese investment firm that

helps life sciences companies to develop transformative therapies.

WuXi Healthcare Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments18
Current Portfolio Count12
Total Portfolio Exits0

Top Investment Stages

Series A7 (38.9%)
Series B7 (38.9%)
Series C2 (11.1%)
Series D1 (5.6%)
Series E1 (5.6%)

Stage Mix

Series A 39%Series B 39%Series C 11%Series D 6%Series E 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

LifeMine Therapeutics logo

LifeMine Therapeutics

Halda Therapeutics logo

Halda Therapeutics

Refuge Biotechnologies logo

Refuge Biotechnologies

Ideaya Biosciences logo

Ideaya Biosciences

Medeor Therapeutics logo

Medeor Therapeutics

Vivace Therapeutics logo

Vivace Therapeutics

Avelas Biosciences logo

Avelas Biosciences

Twist Bioscience logo

Twist Bioscience

Syros Pharmaceuticals logo

Syros Pharmaceuticals

23andMe logo

23andMe

Tunitas Therapeutics logo

Tunitas Therapeutics

Unity Biotechnology logo

Unity Biotechnology

WuXi Healthcare Ventures - Similar Investment Firms

Frontline BioVentures logo

Frontline BioVentures

Healthcare Ventures logo

Healthcare Ventures

hcven.com

China Life Healthcare Fund logo

China Life Healthcare Fund

BioVenture logo

BioVenture

bioventure.com.cn

Inbio Ventures logo

Inbio Ventures

Nan Fung Life Sciences logo

Nan Fung Life Sciences

Wu Capital logo

Wu Capital

Wuxi Venture Capital Group logo

Wuxi Venture Capital Group

wxvcg.com

Bioventures Investors logo

Bioventures Investors

Catalyst Health Ventures logo

Catalyst Health Ventures

Ambix Healthcare Partners logo

Ambix Healthcare Partners

Wuyuan Capital logo

Wuyuan Capital

WFD Ventures logo

WFD Ventures

Vectis Healthcare & Life Sciences Fund logo

Vectis Healthcare & Life Sciences Fund

3H Health Investment logo

3H Health Investment

WuXi Healthcare Ventures - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions